EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 32 / No 3 (Mars 2016) Med Sci (Paris), 32 3 (2016) 260-266 References
Free Access
Issue
Med Sci (Paris)
Volume 32, Number 3, Mars 2016
Page(s) 260 - 266
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20163203010
Published online 23 March 2016
  1. Maziak W, Behrens T, Brasky TM, et al. Are asthma and allergies in children and adolescents increasing? Results from ISAAC phase I and phase III surveys in Munster. Germany. Allergy 2003 ; 58 : 572–579. [CrossRef] [Google Scholar]
  2. Saito H. Much atopy about the skin: genome-wide molecular analysis of atopic eczema. Int Arch Allergy Immunol 2005 ; 137 : 319–325. [CrossRef] [PubMed] [Google Scholar]
  3. Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010 ; 105 : 99–106; quiz 7–9, 17. [CrossRef] [PubMed] [Google Scholar]
  4. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999 ; 17 : 255–281. [CrossRef] [PubMed] [Google Scholar]
  5. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004 ; 59 : 469–478. [CrossRef] [PubMed] [Google Scholar]
  6. Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997 ; 385 : 640–644. [CrossRef] [PubMed] [Google Scholar]
  7. Booth BW, Sandifer T, Martin EL, Martin LD. IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17. Respir Res 2007 ; 8 : 51. [CrossRef] [PubMed] [Google Scholar]
  8. Hartl D, He CH, Koller B, et al. Acidic mammalian chitinase is secreted via an ADAM17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cells. J Biol Chem 2008 ; 283 : 33472–33482. [CrossRef] [PubMed] [Google Scholar]
  9. Nakayama T, Watanabe Y, Oiso N, et al. Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1. J Immunol 2010 ; 185 : 6472–6479. [CrossRef] [PubMed] [Google Scholar]
  10. Schwaeble WJ, Stover CM, Schall TJ, et al. Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Lett 1998 ; 439 : 203–207. [CrossRef] [PubMed] [Google Scholar]
  11. Lucas AD, Chadwick N, Warren BF, et al. The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol 2001 ; 158 : 855–866. [CrossRef] [PubMed] [Google Scholar]
  12. Rimaniol AC, Till SJ, Garcia G, et al. The CX3C chemokine fractalkine in allergic asthma and rhinitis. J Allergy Clin Immunol 2003 ; 112 : 1139–1146. [CrossRef] [PubMed] [Google Scholar]
  13. Echigo T, Hasegawa M, Shimada Y, et al. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. J Allergy Clin Immunol 2004 ; 113 : 940–948. [CrossRef] [PubMed] [Google Scholar]
  14. El-Shazly A, Berger P, Girodet PO, et al. Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J Immunol 2006 ; 176 : 1860–1868. [CrossRef] [PubMed] [Google Scholar]
  15. Kim KW, Vallon-Eberhard A, Zigmond E, et al. In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood 2011 ; 118 : e156–e167. [CrossRef] [PubMed] [Google Scholar]
  16. Harrison JK, Jiang Y, Chen S, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 1998 ; 95 : 10896–10901. [CrossRef] [Google Scholar]
  17. Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997 ; 91 : 521–530. [CrossRef] [PubMed] [Google Scholar]
  18. Jung S, Aliberti J, Graemmel P, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000 ; 20 : 4106–4114. [CrossRef] [PubMed] [Google Scholar]
  19. Chang SY, Song JH, Guleng B, et al. Circulatory antigen processing by mucosal dendritic cells controls CD8+ T cell activation. Immunity 2013 ; 38 : 153–165. [CrossRef] [PubMed] [Google Scholar]
  20. Liu ZQ, Wu Y, Song JP, et al. Tolerogenic CX3CR1+ B cells suppress food allergy-induced intestinal inflammation in mice. Allergy 2013 ; 68 : 1241–1248. [CrossRef] [PubMed] [Google Scholar]
  21. Fraticelli P, Sironi M, Bianchi G, et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 2001 ; 107 : 1173–1181. [CrossRef] [PubMed] [Google Scholar]
  22. Ning W, Li CJ, Kaminski N, et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 2004 ; 101 : 14895–14900. [CrossRef] [Google Scholar]
  23. Balabanian K, Foussat A, Dorfmuller P, et al. CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 2002 ; 165 : 1419–1425. [CrossRef] [PubMed] [Google Scholar]
  24. Marasini B, Cossutta R, Selmi C, et al. Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension. Clin Dev Immunol 2005 ; 12 : 275–279. [CrossRef] [PubMed] [Google Scholar]
  25. Murphy G, Caplice N, Molloy M. Fractalkine in rheumatoid arthritis: a review to date. Rheumatology (Oxford) 2008 ; 47 : 1446–1451. [CrossRef] [PubMed] [Google Scholar]
  26. Lesnik P, Haskell CA, Charo IF. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 2003 ; 111 : 333–340. [CrossRef] [PubMed] [Google Scholar]
  27. Tremblay K, Lemire M, Provost V, et al. Association study between the CX3CR1 gene and asthma. Genes Immun 2006 ; 7 : 632–639. [CrossRef] [PubMed] [Google Scholar]
  28. Depner M, Kormann MS, Klopp N, et al. CX3CR1 Polymorphisms are associated with atopy but not asthma in German children. Int Arch Allergy Immunol 2007 ; 144 : 91–94. [CrossRef] [PubMed] [Google Scholar]
  29. Mionnet C, Buatois V, Kanda A, et al. CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung. Nat Med 2010 ; 16 : 1305–1312. [CrossRef] [PubMed] [Google Scholar]
  30. Staumont-Salle D, Fleury S, Lazzari A, et al. CX3CL1 (fractalkine) and its receptor CX3CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin. J Exp Med 2014 ; 211 : 1185–1196. [CrossRef] [PubMed] [Google Scholar]
  31. Nishimura M, Umehara H, Nakayama T, et al. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 2002 ; 168 : 6173–6180. [CrossRef] [PubMed] [Google Scholar]
  32. Garin A, Pellet P, Deterre P, et al. Cloning and functional characterization of the human fractalkine receptor promoter regions. Biochem J 2002 ; 368 : 753–760. [CrossRef] [PubMed] [Google Scholar]
  33. Ramos MV, Fernandez GC, Brando RJ, et al. Interleukin-10 and interferon-gamma modulate surface expression of fractalkine-receptor (CX(3)CR1) via PI3K in monocytes. Immunology 2010 ; 129 : 600–609. [CrossRef] [PubMed] [Google Scholar]
  34. Sechler JM, Barlic J, Grivel JC, Murphy PM. IL-15 alters expression and function of the chemokine receptor CX3CR1 in human NK cells. Cell Immunol 2004 ; 230 : 99–108. [CrossRef] [PubMed] [Google Scholar]
  35. Meucci O, Fatatis A, Simen AA, Miller RJ. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 2000 ; 97 : 8075–8080. [CrossRef] [Google Scholar]
  36. Tong N, Perry SW, Zhang Q, et al. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol 2000 ; 164 : 1333–1339. [CrossRef] [PubMed] [Google Scholar]
  37. Boehme SA, Lio FM, Maciejewski-Lenoir D, et al. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol 2000 ; 165 : 397–403. [CrossRef] [PubMed] [Google Scholar]
  38. Mizuno T, Kawanokuchi J, Numata K, Suzumura A. Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res 2003 ; 979 : 65–70. [CrossRef] [PubMed] [Google Scholar]
  39. Landsman L, Bar-On L, Zernecke A, et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009 ; 113 : 963–972. [CrossRef] [PubMed] [Google Scholar]
  40. Maciejewski-Lenoir D, Chen S, Feng L, et al. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J Immunol 1999 ; 163 : 1628–1635. [PubMed] [Google Scholar]
  41. Cambien B, Pomeranz M, Schmid-Antomarchi H, et al. Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 2001 ; 97 : 2031–2037. [CrossRef] [PubMed] [Google Scholar]
  42. Meucci O, Fatatis A, Simen AA, et al. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 1998 ; 95 : 14500–14505. [CrossRef] [Google Scholar]
  43. Kansra V, Groves C, Gutierrez-Ramos JC, Polakiewicz RD. Phosphatidylinositol 3-kinase-dependent extracellular calcium influx is essential for CX(3)CR1-mediated activation of the mitogen-activated protein kinase cascade. J Biol Chem 2001 ; 276 : 31831–31838. [CrossRef] [PubMed] [Google Scholar]
  44. Davis CN, Harrison JK. Proline 326 in the C terminus of murine CX3CR1 prevents G-protein and phosphatidylinositol 3-kinase-dependent stimulation of Akt and extracellular signal-regulated kinase in Chinese hamster ovary cells. J Pharmacol Exp Ther 2006 ; 316 : 356–363. [CrossRef] [PubMed] [Google Scholar]
  45. Combadiere C, Gao J, Tiffany HL, Murphy PM. Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine. Biochem Biophys Res Commun 1998 ; 253 : 728–732. [CrossRef] [PubMed] [Google Scholar]
  46. Lopez Vina A. Severe asthma refractory to treatment: concepts and realities. Arch Bronconeumol 2006 ; 42 : 20–25. [CrossRef] [Google Scholar]
  47. O’Byrne PM. The demise of anti IL-5 for asthma, or not. Am J Respir Crit Care Med 2007 ; 176 : 1059–1060. [CrossRef] [PubMed] [Google Scholar]
  48. Froidure A, Charles P. Les cellules dendritiques humaines dans l’asthme et la rhinite allergique. Med Sci (Paris) 2015 ; 31 : 151–158. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  49. De Masson A, Bouaziz JD, Battistella M, et al. Immunopathologie du psoriasis : from bench to bedside. Med Sci (Paris) 2016 ; 32 : 253–259. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.